1,071
Views
11
CrossRef citations to date
0
Altmetric
Research

Low‐dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials

, MD, , MD, , MD FACS & , PhD
Pages 131-139 | Received 02 Jul 2018, Accepted 20 Sep 2018, Published online: 21 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jihei Sara Lee & Chan Yun Kim. (2022) Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy. Expert Review of Clinical Pharmacology 15:8, pages 911-919.
Read now

Articles from other publishers (9)

José Alvaro P. Gomes, Dimitri T. Azar, Christophe Baudouin, Etty Bitton, Wei Chen, Farhad Hafezi, Pedram Hamrah, Ruth E. Hogg, Jutta Horwath-Winter, Georgios A. Kontadakis, Jodhbir S. Mehta, Elisabeth M. Messmer, Victor L. Perez, David Zadok & Mark D.P. Willcox. (2023) TFOS Lifestyle: Impact of elective medications and procedures on the ocular surface. The Ocular Surface 29, pages 331-385.
Crossref
Marissa K. Shoji, Zahra Markatia, Kambiz Ameli, Mandah Bayaraa, Kevin D. Clauss, Shoaib Ugradar & Wendy W. Lee. (2023) The effects of topical oxymetazoline on eyelid position, eye redness, and patient-reported eye appearance: A randomized controlled trial. Journal of Plastic, Reconstructive & Aesthetic Surgery 80, pages 66-74.
Crossref
Fikret Ucar & Halil İbrahim Yener. (2022) Can bleeding in trabeculectomy be decreased? Effectiveness of brimonidine pre-treatment. European Journal of Ophthalmology 32:6, pages 3476-3481.
Crossref
Shudan Wang, Lingjia Liu, Tomas Blanco, Hongyan Ge, Yutong Xia, Kunpeng Pang, Yihe Chen & Reza Dana. (2022) Therapeutic efficacy of topical blockade of substance P in experimental allergic red eye. The Ocular Surface 26, pages 184-190.
Crossref
Rohan Bir Singh, Lingjia Liu, Ann Yung, Sonia Anchouche, Sharad K. Mittal, Tomas Blanco, Thomas H. Dohlman, Jia Yin & Reza Dana. (2021) Ocular redness – II: Progress in development of therapeutics for the management of conjunctival hyperemia. The Ocular Surface 21, pages 66-77.
Crossref
Mari Carmen Desco, Julio Cesar Molina Martín, Jorge Mataix-Boronat, Isabel Pascual-Camps, Elena Palacios-Pozo, Marisa Barón-García, David P Piñero & Amparo Navea-Tejerina. (2021) Prophylactic effect of brimonidine to minimize the incidence of subconjunctival hemorrhage in the early postoperative period after 23G pars plana vitrectomy. Therapeutic Advances in Ophthalmology 13, pages 251584142110457.
Crossref
N Cimolai. (2020) A review of neuropsychiatric adverse events from topical ophthalmic brimonidine. Human & Experimental Toxicology 39:10, pages 1279-1290.
Crossref
O. N. Onufriichuk, I. R. Gazizova, A. V. Kuroyedov & A. V. Seleznev. (2020) The effect of the main active substances of antihypertensive eye drops on condition of the eyes of glaucoma patients. Pacific Medical Journal:3, pages 5-10.
Crossref
Nofar Kimchi & Leonard Bielory. (2020) The allergic eye: recommendations about pharmacotherapy and recent therapeutic agents. Current Opinion in Allergy & Clinical Immunology 20:4, pages 414-420.
Crossref